Prakash

Author's details

Name: Prakash Nallathamby
Date registered: July 27, 2017

Latest posts

  1. Military Health Sciences Research Symposium 2024. (Aug 26-29, 2024, Kissimmee FL) — August 30, 2024
  2. Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa — August 21, 2024
  3. Precision Health and Diagnostics Session Chair at Techconnect World Innovation Conference (2024) — June 19, 2024
  4. MTEC Annual meeting in Baltimore MD (May 24, 2024) — May 24, 2024
  5. Nallathamby Lab’s Kevin Armknecht is Invited to Present at the Midwest Microscopy and Microanalysis Workshop 2024 — May 7, 2024

Author's posts listings

Apr 08

Label-Free, Magnetic Nanocarrier based, Precision Combinatorial Chemotherapeutics Treatment Against Metastatic Cancer for Recurrence-Free Survival

Categories:

AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, Combination chemotherapy, Harper Cancer Research Institute

by

╪1,3Margo Waters, ╪1,3Juliane Hopf, 1,3Paul Helquist, 2Vincent Jo Davisson, and 1,3Prakash. D. Nallathamby 1University of Notre Dame, Notre Dame USA; 2Purdue University, Lafayette, USA; 3NDnano, Notre Dame, USA ╪ Equal contributors The leading cause of fatalities in breast cancer is metastasis.1 To increase the success rate of metastasis-free survival, there is a need to tackle …

Continue reading »

Tags:

Apr 03

Society for Biomaterials – Seattle 2019

Categories:

AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Conference abstracts, metastatic cancer cells, multidrug resistance, SFB2019

by

I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …

Continue reading »

Tags: , , ,

Feb 14

Center for the Translational Sciences Indiana Awards us Seed Grant for an Innovative Antibiotic Free Nanotherapeutics to Combat Multi-drug Resistant Bacterial Infections

Categories:

AD&T Notre Dame, antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Grants funding, multidrug resistance

by

Biomedical research is at risk of losing the antibiotics vs. pathogens arms race. Pneumonia, tuberculosis, gonorrhea, and salmonellosis are becoming harder and sometimes impossible to treat due to the fast emergence and global spread of new antibiotic resistance. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries …

Continue reading »

Tags:

Feb 14

American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo

Categories:

AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells

by

We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …

Continue reading »

Tags:

Feb 11

Read our review article on novel ‘Blue-sky’ future applications of nanoparticles in the Biomedical Field

Categories:

AD&T Notre Dame, Berthiaume Institute for Precision Health, Harper Cancer Research Institute, Review

by

Over the last two decades, nanotechnology has become one of the most dynamically evolving field of research. Various types of nanoparticles are widely exploited to extend our understanding of biological interactions at the molecular level. They are actively engaged in the biomedical research for imaging, biosensing, drug delivery and/or concurrent therapy. Recent progress on this …

Continue reading »

Tags:

Nov 28

Nallathamby Laboratory in the Press for Novel Approach to CAR-T Therapy

Categories:

Berthiaume Institute for Precision Health, Harper Cancer Research Institute, Hybrid nanoparticles, Immunotherapy

by

Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …

Continue reading »

This post has no tag

Aug 30

Nanoparticles that act as an “ON and OFF” switch to improve the safety and effectiveness of CAR-T cancer therapy

Categories:

AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Harper Cancer Research Institute, Immunotherapy, metastatic cancer cells

by

Always thankful for the internal support from Notre Dame Research #notredameresearch for supporting high risk-high gain projects such as mine. Here’s hoping that my faculty research support program initiation grant (FRSP-IG) #FRSP will pave the way for safer, more accessible CAR-T therapies and better quality of life for patients. https://research.nd.edu/news/developing-an-on-and-off-switch-for-breast-cancer-treatment/ The biggest bottle neck in Chimeric …

Continue reading »

Tags:

Jul 02

Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters

Categories:

AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells

by

Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/

Tags:

May 14

TechConnect 2018 an SBIR/STTR Haven

Categories:

Berthiaume Institute for Precision Health, Biomedical Imaging, Conference abstracts, SBIR/STTR

by

TechConnect #techconnect keeps getting better every year! Anaheim was a great location, with a good mix of entrepreneurs and investors! Looking forward to the next one in Boston in May 2019. I chaired a very engaging panel of experts who elaborated on the biggest problem facing the industrial production of uniform nanoparticles. I showcased Notre …

Continue reading »

This post has no tag

May 04

College of Science Joint Annual Meeting (CoS-JAM) Poster Presentation (May 4, 2018)

Categories:

antibiotics, Antimicrobial, Berthiaume Institute for Precision Health, Conference abstracts

by

The poster presented by the undergraduate researchers (Margo Waters and Veronica Kalwatjys), explaining their work on a rationally designed, modular antimicrobial nanoparticle system was well received at COS-JAM 2018. Margo worked on the synthesis of the antimicrobial nanoparticles. Veronica has started testing the antimicrobial properties of these nanoparticles under the direction of Dr. Juliane Hopf. …

Continue reading »

This post has no tag

Older posts «

» Newer posts